Literature DB >> 25955229

Proposed genitalia contouring guidelines in anal cancer intensity-modulated radiotherapy.

C Brooks1, V N Hansen1, A Riddell1, V A Harris1, D M Tait1.   

Abstract

OBJECTIVE: Intensity-modulated radiotherapy (IMRT) for anal canal carcinoma (ACC) is associated with favourable toxicity outcomes. Side effects include sexual dysfunction, skin desquamation, pain and fibrosis to perineum and genitalia region. The genitalia are situated anterior to the primary ACC between two inguinal regions providing a challenging structure to avoid. Techniques improving outcomes require robust, consistent genitalia contouring to ensure standardization and production of fully optimized IMRT plans. Official recommendations for genitalia contouring are lacking. We describe a potential genitalia contouring atlas for ACC radiotherapy.
METHODS: Following a review of genitalia CT anatomy, a contouring atlas was generated for male and female patients positioned prone and supine. Particular attention was paid to the reproducibility of the genitalia contour in all planes.
RESULTS: Male and female genitalia positioned prone and supine are described and represented visually through a contouring atlas. Contoured areas in males include penis and scrotum, and in females include clitoris, labia majora and minora. The muscles, bone, prostate, vagina, cervix and uterus should be excluded. The genitalia contour extends laterally to inguinal creases and includes areas of fat and skin anterior to the symphysis pubis for both genders.
CONCLUSION: This atlas provides descriptive and visual guidance enabling more consistent genitalia delineation for both genders when prone and supine. The atlas can be used for other sites requiring radiotherapy planning. ADVANCES IN KNOWLEDGE: This atlas presents visual contouring guidance for genitalia in ACC radiotherapy for the first time. Contouring methods provide reproducible genitalia contours that allow the provision of accurate dose toxicity data in future studies.

Entities:  

Mesh:

Year:  2015        PMID: 25955229      PMCID: PMC4628528          DOI: 10.1259/bjr.20150032

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

Review 1.  Intensity-modulated radiation therapy for anal cancer.

Authors:  Brian G Czito; Joseph M Pepek; Jeffrey J Meyer; Sua Yoo; Christopher G Willett
Journal:  Oncology (Williston Park)       Date:  2009-11-15       Impact factor: 2.990

2.  Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.

Authors:  Jose G Bazan; Wendy Hara; Annie Hsu; Pamela A Kunz; James Ford; George A Fisher; Mark L Welton; Andrew Shelton; Daniel S Kapp; Albert C Koong; Karyn A Goodman; Daniel T Chang
Journal:  Cancer       Date:  2011-02-01       Impact factor: 6.860

3.  Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.

Authors:  Michael T Milano; Ashesh B Jani; Karl J Farrey; Carla Rash; Ruth Heimann; Steven J Chmura
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

4.  "Mind the gap"--the impact of variations in the duration of the treatment gap and overall treatment time in the first UK Anal Cancer Trial (ACT I).

Authors:  Rob Glynne-Jones; David Sebag-Montefiore; Richard Adams; Alec McDonald; Simon Gollins; Roger James; John M A Northover; Helen M Meadows; Mark Jitlal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

5.  Intensity-modulated radiation therapy for the treatment of anal cancer.

Authors:  Alexander Lin; Edgar Ben-Josef
Journal:  Clin Colorectal Cancer       Date:  2007-11       Impact factor: 4.481

6.  Organ-sparing Intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans.

Authors:  C J Brooks; Y K Lee; K Aitken; V N Hansen; D M Tait; M A Hawkins
Journal:  Clin Oncol (R Coll Radiol)       Date:  2012-09-14       Impact factor: 4.126

7.  A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer.

Authors:  Kurian Jones Joseph; Alasdair Syme; Cormac Small; Heather Warkentin; Harvey Quon; Sunita Ghosh; Colin Field; Nadeem Pervez; Keith Tankel; Samir Patel; Nawaid Usmani; Diane Severin; Tirath Nijjar; Gino Fallone; John Pedersen
Journal:  Radiother Oncol       Date:  2009-11-04       Impact factor: 6.280

8.  Long-term quality of life after radiotherapy for the treatment of anal cancer.

Authors:  Prajnan Das; Scott B Cantor; Crystal L Parker; Joan B Zampieri; Andrew Baschnagel; Cathy Eng; Marc E Delclos; Sunil Krishnan; Nora A Janjan; Christopher H Crane
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

9.  Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

Authors:  Roger D James; Robert Glynne-Jones; Helen M Meadows; David Cunningham; Arthur Sun Myint; Mark P Saunders; Timothy Maughan; Alec McDonald; Sharadah Essapen; Martin Leslie; Stephen Falk; Charles Wilson; Simon Gollins; Rubina Begum; Jonathan Ledermann; Latha Kadalayil; David Sebag-Montefiore
Journal:  Lancet Oncol       Date:  2013-04-09       Impact factor: 41.316

10.  IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center.

Authors:  Sabine Vieillot; Pascal Fenoglietto; Claire Lemanski; Carmen Llacer Moscardo; Sophie Gourgou; Jean-Bernard Dubois; Norbert Aillères; David Azria
Journal:  Radiat Oncol       Date:  2012-03-23       Impact factor: 3.481

View more
  6 in total

1.  Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.

Authors:  V Dell'Acqua; J Kobiela; F Kraja; M C Leonardi; A Surgo; M A Zerella; S Arculeo; C Fodor; R Ricotti; M G Zampino; S Ravenda; G Spinoglio; R Biffi; A Bazani; R Luraschi; S Vigorito; P Spychalski; R Orecchia; R Glynne-Jones; B A Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-03-28       Impact factor: 3.064

Review 2.  Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review.

Authors:  Deborah C Marshall; Elizabeth S Tarras; Ayesha Ali; Julie Bloom; Mylin A Torres; Jenna M Kahn
Journal:  CA Cancer J Clin       Date:  2022-03-17       Impact factor: 286.130

3.  A first radiotherapy application of functional bulboclitoris anatomy, a novel female sexual organ-at-risk, and organ-sparing feasibility study.

Authors:  Deborah C Marshall; Zahra Ghiassi-Nejad; Allison Powers; Joy S Reidenberg; Pamela Argiriadi; Meng Ru; Vishruta Dumane; Michael Buckstein; Karyn Goodman; Stephanie V Blank; Julie Schnur; Barry Rosenstein
Journal:  Br J Radiol       Date:  2021-06-30       Impact factor: 3.629

4.  Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer.

Authors:  Hendrik Dapper; Markus Oechsner; Stefan Münch; Christian Diehl; Jan C Peeken; Kai Borm; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2020-02-03       Impact factor: 3.621

5.  The impact of contour variation on tumour control probability in anal cancer.

Authors:  Michael P Jones; Jarad Martin; Kerwyn Foo; Patrick Estoesta; Lois Holloway; Michael Jameson
Journal:  Radiat Oncol       Date:  2018-05-18       Impact factor: 3.481

6.  Physician review of image registration and normal structure delineation.

Authors:  William Tyler Turchan; Ritu Arya; Robert Hight; Hania Al-Hallaq; Michael Dominello; Dan Joyce; Bradley P McCabe; Anne R McCall; Eugenia Perevalova; Christopher Stepaniak; Kamil Yenice; Jay Burmeister; Daniel W Golden
Journal:  J Appl Clin Med Phys       Date:  2020-09-28       Impact factor: 2.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.